Evaluating day +90 donor chimerism as a prognostic marker of clinical outcomes among allogeneic hematopoietic cell transplant recipients who received myeloablative conditioning

2026-06-18

PRE

Sara Jubas

Kieran Collins

Kendall Obara

Hsuan-Hui Liu

Ryan M. Kemper

Alexandra L.W. Kelley

Arushi Goel

Tyler Dunlap

Jing Zhu

Riley M. Randolph

Jonathan Ptachcinski

Morgan E. Bizzell

Paul M. Armistead

J. Ryan Shaw

Anson E. Snow

Daniel J. Crona *

DOI：10.1016/j.jtct.2026.06.024

Original

Original request for help

Save

Abstract

En 中文

• Full donor chimerism is associated with improved clinical outcomes • Achievement of full donor chimerism is influenced by the conditioning regimen • First-dose busulfan exposure does not predict unfractionated donor chimerism status

Evaluating day +90 donor chimerism as a prognostic marker of clinical outcomes among allogeneic hematopoietic cell transplant recipients who received myeloablative conditioning

Abstract

Journal

Organization

Cited Papers

Citing Papers